Impact on health outcomes and productive work of adding anti-PD-1 agents to treat early-stage cancers in the United Kingdom: a modelling study.
Saved in:
| Title: | Impact on health outcomes and productive work of adding anti-PD-1 agents to treat early-stage cancers in the United Kingdom: a modelling study. |
|---|---|
| Authors: | Burton H; MSD (UK) Ltd., London, United Kingdom., Tan YZ; Lumanity, Utrecht, Netherlands., Greenall S; Lumanity, London, United Kingdom., Neves C; Lumanity, Utrecht, Netherlands., Macdonald N; MSD (UK) Ltd., London, United Kingdom., Aguiar-Ibáñez R; Merck Canada Inc., Kirkland, QC, Canada. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Oct 30; Vol. 16, pp. 1613120. Date of Electronic Publication: 2025 Oct 30 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1613120 |
